...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: NYAS Epigenetics: Cancer and Beyond Symposium eBriefing

The New York Academy of Sciences eBriefing of the April 28, 2016 Epigenetic: Cancer and Beyond is now online (thanks to RVX_Anonymous on the SH board for first posting).

http://www.nyas.org/Publications/EBriefings/Detail.aspx?cid=36af57a0-910c-48c4-9359-aac40699b65c

That link will take you to the overview. If you click on the "Media" you will see the slides and audio that have been made available. Included are the talks from Resverlogix, given by Ewelina Kulikowski and from Zenith Epigenetics, given by Eric Campeau.

Slides & Audio

Exploiting Epigenetic Therapies for Drug Resistance and Immunomodulation

Roberto Pili (Indiana University School of Medicine)
Slides & Audio

Chromatin Regulators as Cancer Dependencies

Christopher Vakoc (Cold Spring Harbor Laboratory)

Eric Campeau (Zenith Epigenetics)

Share
New Message
Please login to post a reply